Molecule Information
General Information of the Molecule (ID: Mol00728)
Name |
Dihydrofolate reductase/DNA gyrase subunit A/DNA gyrase subunit B (DHFR/GYRA/GYRB)
,Mycobacterium leprae
|
||||
---|---|---|---|---|---|
Molecule Type |
Protein
|
||||
Gene Name |
DHFR/GYRA/GYRB
|
||||
Gene ID | |||||
Uniprot ID | |||||
Click to Show/Hide the Complete Species Lineage | |||||
Type(s) of Resistant Mechanism of This Molecule
ADTT: Aberration of the Drug's Therapeutic Target
Drug Resistance Data Categorized by Drug
Approved Drug(s)
4 drug(s) in total
Clofazimine
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Aberration of the Drug's Therapeutic Target (ADTT) | ||||
Disease Class: Leprosy | [1] | |||
Resistant Disease | Leprosy [ICD-11: 1B20.0] | |||
Resistant Drug | Clofazimine | |||
Molecule Alteration | Missense mutation | folP p.P55L+gyrA p.A91V+gyrB p.A91V |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Mycobacterium leprae isolates | 1769 | ||
In Vivo Model | Footpad granuloma from M. leprae-infected nude mice model | Mus musculus | ||
Experiment for Molecule Alteration |
PCR and single-stranded conformational polymorphism (SSCP) assay | |||
Experiment for Drug Resistance |
Mouse footpad assay | |||
Mechanism Description | The mutations genes reported in this study have been demonstrated to be responsible for drug resistance by mouse footpad assay. | |||
Disease Class: Leprosy | [1] | |||
Resistant Disease | Leprosy [ICD-11: 1B20.0] | |||
Resistant Drug | Clofazimine | |||
Molecule Alteration | Missense mutation | folP p.P55L+gyrA p.D205N+gyrB p.D205N |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Mycobacterium leprae isolates | 1769 | ||
In Vivo Model | Footpad granuloma from M. leprae-infected nude mice model | Mus musculus | ||
Experiment for Molecule Alteration |
PCR and single-stranded conformational polymorphism (SSCP) assay | |||
Experiment for Drug Resistance |
Mouse footpad assay | |||
Mechanism Description | The mutations genes reported in this study have been demonstrated to be responsible for drug resistance by mouse footpad assay. |
Dapsone
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Aberration of the Drug's Therapeutic Target (ADTT) | ||||
Disease Class: Leprosy | [1] | |||
Resistant Disease | Leprosy [ICD-11: 1B20.0] | |||
Resistant Drug | Dapsone | |||
Molecule Alteration | Missense mutation | folP p.P55L+gyrA p.A91V+gyrB p.A91V |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Mycobacterium leprae isolates | 1769 | ||
In Vivo Model | Footpad granuloma from M. leprae-infected nude mice model | Mus musculus | ||
Experiment for Molecule Alteration |
PCR and single-stranded conformational polymorphism (SSCP) assay | |||
Experiment for Drug Resistance |
Mouse footpad assay | |||
Mechanism Description | The mutations genes reported in this study have been demonstrated to be responsible for drug resistance by mouse footpad assay. | |||
Disease Class: Leprosy | [1] | |||
Resistant Disease | Leprosy [ICD-11: 1B20.0] | |||
Resistant Drug | Dapsone | |||
Molecule Alteration | Missense mutation | folP p.P55L+gyrA p.D205N+gyrB p.D205N |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Mycobacterium leprae isolates | 1769 | ||
In Vivo Model | Footpad granuloma from M. leprae-infected nude mice model | Mus musculus | ||
Experiment for Molecule Alteration |
PCR and single-stranded conformational polymorphism (SSCP) assay | |||
Experiment for Drug Resistance |
Mouse footpad assay | |||
Mechanism Description | The mutations genes reported in this study have been demonstrated to be responsible for drug resistance by mouse footpad assay. |
Ofloxacin
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Aberration of the Drug's Therapeutic Target (ADTT) | ||||
Disease Class: Leprosy | [1] | |||
Resistant Disease | Leprosy [ICD-11: 1B20.0] | |||
Resistant Drug | Ofloxacin | |||
Molecule Alteration | Missense mutation | folP p.P55L+gyrA p.A91V+gyrB p.A91V |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Mycobacterium leprae isolates | 1769 | ||
In Vivo Model | Footpad granuloma from M. leprae-infected nude mice model | Mus musculus | ||
Experiment for Molecule Alteration |
PCR and single-stranded conformational polymorphism (SSCP) assay | |||
Experiment for Drug Resistance |
Mouse footpad assay | |||
Mechanism Description | The mutations genes reported in this study have been demonstrated to be responsible for drug resistance by mouse footpad assay. | |||
Disease Class: Leprosy | [1] | |||
Resistant Disease | Leprosy [ICD-11: 1B20.0] | |||
Resistant Drug | Ofloxacin | |||
Molecule Alteration | Missense mutation | folP p.P55L+gyrA p.D205N+gyrB p.D205N |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Mycobacterium leprae isolates | 1769 | ||
In Vivo Model | Footpad granuloma from M. leprae-infected nude mice model | Mus musculus | ||
Experiment for Molecule Alteration |
PCR and single-stranded conformational polymorphism (SSCP) assay | |||
Experiment for Drug Resistance |
Mouse footpad assay | |||
Mechanism Description | The mutations genes reported in this study have been demonstrated to be responsible for drug resistance by mouse footpad assay. |
Rifampin
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Aberration of the Drug's Therapeutic Target (ADTT) | ||||
Disease Class: Leprosy | [1] | |||
Resistant Disease | Leprosy [ICD-11: 1B20.0] | |||
Resistant Drug | Rifampin | |||
Molecule Alteration | Missense mutation | folP p.P55L+gyrA p.A91V+gyrB p.A91V |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Mycobacterium leprae isolates | 1769 | ||
In Vivo Model | Footpad granuloma from M. leprae-infected nude mice model | Mus musculus | ||
Experiment for Molecule Alteration |
PCR and single-stranded conformational polymorphism (SSCP) assay | |||
Experiment for Drug Resistance |
Mouse footpad assay | |||
Mechanism Description | The mutations genes reported in this study have been demonstrated to be responsible for drug resistance by mouse footpad assay. | |||
Disease Class: Leprosy | [1] | |||
Resistant Disease | Leprosy [ICD-11: 1B20.0] | |||
Resistant Drug | Rifampin | |||
Molecule Alteration | Missense mutation | folP p.P55L+gyrA p.D205N+gyrB p.D205N |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Mycobacterium leprae isolates | 1769 | ||
In Vivo Model | Footpad granuloma from M. leprae-infected nude mice model | Mus musculus | ||
Experiment for Molecule Alteration |
PCR and single-stranded conformational polymorphism (SSCP) assay | |||
Experiment for Drug Resistance |
Mouse footpad assay | |||
Mechanism Description | The mutations genes reported in this study have been demonstrated to be responsible for drug resistance by mouse footpad assay. |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.